NRX-101 for Bipolar Depression With Subacute Suicidal Ideation

Clinical trial NCT03395392 · COMPLETED

Trial details

NCT number: NCT03395392
Sponsor: NeuroRx, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bipolar Depression Suicidal Ideation and Behavior

Start date: 2022-05-12
Primary completion: 2024-02-28
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.